Skip to main content

US ClosedU.S. Closed

IBRX: ImmunityBio, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

ImmunityBio, Inc. is a clinical-stage biotechnology firm, founded in 2014 and based in San Diego, California.

52W Range

58thpctl

Volume

0.66×avg

Market Cap

8.43BUSD

P/E Ratio

-8.3TTM

Div Yield

-ann

Loading chart data...

Current StateState loading

ImmunityBio, Inc.

IBRXNASDAQ Global Select·USD·Closed

ImmunityBio, Inc.

IBRXNASDAQ·USD·Closed

$8.05

−4.17%

$8.05

−$0.35 (4.17%)

52W Range

58thpctl

Volume

0.66×avg

Mkt Cap

8.43BUSD

P/E

-8.3TTM

Div Yield

–ann